IRIS
CERNARO, Valeria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.166
NA - Nord America 5.507
AS - Asia 3.253
SA - Sud America 969
AF - Africa 105
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 6
Totale 16.020
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.358
RU - Federazione Russa 3.467
SG - Singapore 1.259
CN - Cina 976
BR - Brasile 827
IE - Irlanda 707
SE - Svezia 595
IT - Italia 357
HK - Hong Kong 345
DE - Germania 251
VN - Vietnam 195
FR - Francia 183
PL - Polonia 170
GB - Regno Unito 142
IN - India 123
FI - Finlandia 113
BD - Bangladesh 75
CA - Canada 69
AR - Argentina 54
TR - Turchia 51
MX - Messico 44
ZA - Sudafrica 34
IQ - Iraq 32
EC - Ecuador 28
BE - Belgio 24
JP - Giappone 24
PK - Pakistan 24
NL - Olanda 22
ES - Italia 21
CZ - Repubblica Ceca 20
ID - Indonesia 20
UZ - Uzbekistan 19
CO - Colombia 18
AT - Austria 17
UA - Ucraina 17
KE - Kenya 16
MA - Marocco 13
VE - Venezuela 13
AE - Emirati Arabi Uniti 12
JM - Giamaica 11
SA - Arabia Saudita 11
AU - Australia 10
AZ - Azerbaigian 9
EG - Egitto 9
PY - Paraguay 9
CH - Svizzera 8
KG - Kirghizistan 8
AL - Albania 7
CI - Costa d'Avorio 7
CL - Cile 7
IL - Israele 7
PE - Perù 7
PH - Filippine 7
TN - Tunisia 7
DO - Repubblica Dominicana 6
NP - Nepal 6
DZ - Algeria 5
ET - Etiopia 5
EU - Europa 5
HN - Honduras 5
MY - Malesia 5
NO - Norvegia 5
PS - Palestinian Territory 5
BG - Bulgaria 4
DK - Danimarca 4
JO - Giordania 4
LT - Lituania 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
RO - Romania 4
AM - Armenia 3
BH - Bahrain 3
BY - Bielorussia 3
GR - Grecia 3
KR - Corea 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
LK - Sri Lanka 3
MD - Moldavia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AO - Angola 2
BN - Brunei Darussalam 2
BO - Bolivia 2
GE - Georgia 2
GT - Guatemala 2
GY - Guiana 2
HU - Ungheria 2
KZ - Kazakistan 2
NG - Nigeria 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
SN - Senegal 2
TJ - Tagikistan 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CR - Costa Rica 1
DM - Dominica 1
Totale 16.001
Salva come PNG Salva come JPEG
Città #
Ashburn 991
Moscow 951
Dublin 705
Dallas 697
Singapore 688
Chandler 572
Hong Kong 342
Nyköping 332
Beijing 323
San Jose 318
New York 161
The Dalles 161
Warsaw 157
Los Angeles 138
Munich 113
Dearborn 111
Boardman 109
Princeton 104
Jacksonville 101
Lauterbourg 95
Medford 93
Ann Arbor 90
Messina 80
Des Moines 75
Cambridge 72
São Paulo 68
Ho Chi Minh City 64
Jinan 55
Shenyang 49
Tianjin 49
Houston 46
Bremen 44
Redondo Beach 44
Buffalo 41
Frankfurt am Main 41
Hanoi 41
Hyderabad 40
Santa Clara 40
San Mateo 39
Turku 37
Orem 35
Council Bluffs 29
Pune 29
Seattle 28
Wilmington 28
Brooklyn 27
Lancaster 27
Guangzhou 26
Montreal 26
Catania 25
Rio de Janeiro 23
Brussels 22
Denver 22
Johannesburg 22
Nanjing 22
Chicago 20
Tokyo 20
Hebei 19
Manchester 19
Mexico City 19
Stockholm 19
Belo Horizonte 18
Curitiba 17
Poplar 17
Ankara 16
Haikou 16
Hangzhou 16
London 16
San Francisco 16
Baghdad 15
Brno 15
Ningbo 15
Phoenix 15
Rome 15
Tashkent 15
Brasília 14
Chennai 14
Toronto 14
Düsseldorf 13
Amsterdam 12
Jiaxing 12
Lentini 12
Nairobi 12
Palermo 12
Shanghai 12
Milan 11
Nuremberg 11
Taizhou 11
Wroclaw 11
Zhengzhou 11
Calgary 10
Campinas 10
Dong Ket 10
Goiânia 10
Guayaquil 10
Istanbul 10
Jakarta 10
Miami 10
Porto Alegre 10
Portsmouth 10
Totale 9.288
Salva come PNG Salva come JPEG
Nome #
[Long-term outcome of renal function in women with preeclampia and pregestational diabetes] 254
[Periorbital purpura: a pathognomonic but late sign of AL amyloidosis] / Porpora periorbitaria: un segnale patognomonico ma tardivo di amiloidosi AL 241
[Lupus Nephritis and Enteritis, a dual simultaneous involvement with Arteriolar Thrombosis] 231
[Complement factor B mutation in atypical hemolytic uremic syndrome. Rare cause of rare disease] 226
[From hyponatremia to tolvaptan] 225
Metformin-related lactic acidosis: is it a myth or an underestimated reality? 222
Auxine: thermodynamic properties, complexing ability and dosage in human serium 218
ANTI-INFLAMMATORY ACTION OF DENOSUMAB IN VIVO AND IN VITRO 214
[From oxygen to erythropoietin, as a protagonist of the skin-brain-kidney axis]. 210
[Long-term outcome of renal function in women with preeclampia and pregestational diabetes] 209
Mortalità e morbidità dei pazienti dializzati in Sicilia: studio epidemiologico analitico sul confronto tra metodiche convettive e diffusive 206
Auxin induces cell proliferation in an experimental model of mammalian renal tubular epithelial cells 199
Sclerostin levels in uremic patients: a link between bone and vascular disease 198
AKI - EXPERIMENTAL MODELS 194
Role of Paricalcitol in Modulating the Immune Response in Patients with Renal Disease 194
Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure 193
Down with the erythropoietin. Long live the erythropoietin! 187
Fibrosis, regeneration and cancer: what is the link? 185
The Myth of Water and Salt: From Aquaretics to Tenapanor 185
Marked improvement of thyroid function and autoimmunity by Aloe barbadensis miller juice in patients with subclinical hypothyroidism 181
Delayed graft function and chronic allograft nephropathy: Diagnostic and prognostic role of neutrophil gelatinase-associated lipocalin 180
A new therapy for kidney injury: regeneration. 179
Acetate-free biofiltration to remove fibroblast growth factor 23 in hemodialysis patients: a pilot study 176
Kidney disease and psoriasis: novel evidences beyond old concepts 175
Beneficial effects of oral pure caffeine on oxidative stress 175
Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis 175
Before and after preeclampsia: What biomarkers are there? 171
Erythropoietin and the truths of science. 166
Apelin, Plasmatic Osmolality and Hypotension in Dialyzed Patients. 166
Opposite actions of urotensin II and relaxin-2 on cellular expression of fibronectin in renal fibrosis: A preliminary experimental study 166
Convective Dialysis Reduces Mortality Risk: Results From a Large Observational, Population-Based Analysis 165
Negative Emotions in End-Stage Renal Disease: Are Anxiety Symptoms Related to Levels of Circulating Catecholamines? 163
Relaxin: New Pathophysiological Aspects and Pharmacological Perspectives for an Old Protein. 162
Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis 161
Renoprotective effect of erythropoietin in zebrafish after administration of gentamicin: an immunohistochemical study for β-catenin and c-kit expression 159
Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease 157
L’ERITROPOIETINA HA AZIONE NEFROPROTETTIVA IN UN MODELLO SPERIMENTALE DI ZEBRAFISH (DANIO RERIO) DOPO SOMMINISTRAZIONE DI GENTAMICINA 156
Kidney biopsy in type 2 diabetic patients: Critical reflections on present indications and diagnostic alternatives 156
Vascular access for hemodialysis: current perspectives 155
Semaphorin 3A serum levels are influenced by haemodialysis: what clinical significance? 154
Nephro-oncology: a link in evolution 154
Gender differences in new hypoglycemic drug effects on renal outcomes: a systematic review 154
The relationship between coping, emotion regulation, and quality of life of patients on dialysis 152
COMPARISON OF SEVELAMER, SEVELAMER CARBONATE AND LANTHANIUM CARBONATE IN VITRO AND IN VIVO 151
From water to aquaretics: a legendary route. 151
Indole-3-acetic acid correlates with monocyte-to-high-density lipoprotein (HDL) ratio (MHR) in chronic kidney disease patients 151
Salt-water imbalance and fluid overload in hemodialysis patients: a pivotal role of corin 149
Squilibri idrico-salini e sovraccarico di liquidi nei pazienti dializzati, il ruolo centrale di Corin 149
Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases 149
Correlation between Hyperkalemia and the Duration of Several Hospitalizations in Patients with Chronic Kidney Disease 148
Kidney-lung connections in acute and chronic diseases: current perspectives 148
Xanthine oxidase inhibitors for improving renal function in chronic kidney disease patients: An updated systematic review and meta-analysis 146
Erithropoietin exerts a renoprotective action in an experimental model of zebrafish (Danio Rerio) after administration of gentamicin 145
An overview of experimental and early investigational therapies for the treatment of polycystic kidney disease 143
Regenerative medicine: does Erythropoietin have a role? 142
Role of Vitamin D in Vascular Complications and Vascular Access Outcome in Patients with Chronic Kidney Disease 141
CIGARETTE SMOKE AND ENDOTHELIAL DYSFUNCTION: NGAL A NEW BIOMARKER 140
SCLEROSTIN CAN BE A NEW "KEY PLAYER" IN VASCULARCALCIFICATION IN CKD? 140
Cross-sectional evaluation of kidney function in hospitalized patients: estimated GFR versus renal scintigraphy 139
Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients 138
L'AUXINA INDUCE PROLIFERAZIONE CELLULARE IN UN MODELLO SPERIMENTALE DI CELLULE EPITELIALI TUBULARI RENALI 138
Monoclonal antibodies for renal diseases: current concepts and ongoing treatments 138
New options for the management of polycystic kidney disease 136
Stress-induced hashitoxicosis: Case report and relative HLA serotype and genotype 136
Maternal and Fetal Outcomes of Pregnancy in Nephrotic Syndrome Due to Primary Glomerulonephritis 136
Proteinuric effect of transcranial magnetic stimulation in healthy subjects and diabetic patients with stage 3-4 CKD 135
Novel avenues for treating diabetic nephropathy: new investigational drugs 134
Renal biopsy: Still a landmark for the nephrologist 131
COMPARISON OF FORMULAS TO ESTIMATE THE GLOMERULAR FILTRATION RATE WITH THAT OF SCINTIGRAPHY EVALUATION OF KIDNEY FUNCTION IN HOSPITALIZED PATIENTS 131
Renal function is associated with changes in bone mineral density in postmenopausal osteoporotic women treated with Denosumab: data from a retrospective cohort study 129
QUANTITATIVE ULTRASOUND OF BONE AND HANDGRIP STRENGTH ARE RELATED TO FRACTURE RISK IN HEMODIALYSIS PATIENTS 128
Complement Inhibition Therapy and Dialytic Strategies in Paroxysmal Nocturnal Hemoglobinuria: The Nephrologist's Opinion 128
Unexpected hypercalcemia in a diabetic patient with kidney disease 126
RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitus 126
Erythropoiesis and chronic kidney disease–related anemia: From physiology to new therapeutic advancements 125
NGAL AND ANESTHETICS: PROTECTIVE ROLE OF SEVOFLURANE 124
Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study 122
Role of Vitamin D Status in Diabetic Patients with Renal Disease 122
FP042AUXIN INDUCES CELL PROLIFERATION IN AN EXPERIMENTAL MODEL OF MAMMALIAN RENAL TUBULAR EPITHELIAL CELLS 122
Autoimmunity and Infection in Glomerular Disease 118
Protective role of vitamin d in renal tubulopathies 118
Modifications in relaxin's serum levels during acetate-free biofiltration (AFB): only a new biomarker? 116
NGAL is a precocious marker of therapeutic response. 115
NEW MARKERS OF VASCULAR AND CARDIAC DYSFUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) 111
Maternal peripheral blood CD34+ cells for prediction of fetal kidney malformations: results from a case-control analysis 111
Does Erythropoietin Always Win? 108
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 105
Endothelial progenitor cells at the interface of chronic kidney disease: from biology to therapeutic advancement 101
Differences in Efficacy between Antibacterial Lock Therapy and the Standard of Care for CVC-Related Infections: A Systematic Review and Meta-Analysis 101
NGAL as an early biomarker of kidney disease in Joubert syndrome: three brothers compared. 100
Comparison between creatinine clearance and eGFRcyst-crea: a real-life experience 98
Commonly used immunosuppressive drugs for kidney diseases and pregnancy: focus on open questions 98
New Insights on the Role of Vitamin D in the Progression of Renal Damage 93
Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine 90
Review and Practical Excursus of the Propensity Score: Low Protein Diet Compared to Mediterranean Diet in Patients With Chronic Kidney Disease 90
Clinical evaluation of the safety, efficacy and tolerability of lanthanum carbonate in the management of hyperphosphatemia in patients with end-stage renal disease 86
Hyperphosphatemia in Chronic Kidney Disease: The Search for New Treatment Paradigms and the Role of Tenapanor 85
UROTENSIN AND RELAXIN: OPPOSITE ACTIONS AND POTENTIAL THERAPEUTIC APPLICATIONS IN RENAL FIBROSIS 85
The future of phosphate binders: a perspective on novel therapeutics 84
Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide 84
Totale 14.983
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.562
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.562
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 0 0 0 0 0 0 17
2021/2022812 13 83 21 48 46 8 50 32 7 171 102 231
2022/20232.054 145 228 87 153 163 189 9 121 877 14 52 16
2023/2024605 37 54 27 42 51 192 18 26 5 59 11 83
2024/20252.555 47 18 50 156 69 106 101 477 603 205 280 443
2025/20268.816 522 531 752 635 775 1.637 972 1.117 1.060 370 218 227
Totale 16.287